The Latest Breaking News on Pharma

An NHS trust’s attempts to bring a crucial drug to market itself is hopeful news for patients, says Dr Catriona Crombie of the medical charity LifeArc

Amid surging medicine demand and ongoing drug shortages, the pharmaceutical industry thrives, driving improved patient outcomes and promising growth opportunities for investors. So, it could be wise to invest in quality pharma stocks ACADIA Pharmaceuticals (ACAD), Neurocrine Biosciences (NBIX), and Supernus Pharmaceuticals (SUPN), which can help you fetch potential financial…

Richard Daly has watched Catalyst Pharmaceuticals transform. Now, as the company's new CEO, he has some metamorphic ideas of his own.

Nvidia stock along with four other leading stocks are in or near buy areas as the market rally appears to be picking up steam.

As the earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation are due to report.

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

The drugmaker increased its market share of the diabetic treatment market by 1.8 percentage points and now has a 34-percent share of the market.

Pharmacists are concerned the recent rise in the cost of NHS drugs will mean more people won’t be able to afford all the medication they need

The pharmaceutical sector is experiencing rapid growth, driven by the ever-rising healthcare needs and the adoption of advanced technologies. Against this backdrop, fundamentally strong pharmaceutical stocks such as Teva Pharmaceutical Industries (TEVA), Neurocrine Biosciences (NBIX), and GSK plc (GSK) could be solid portfolio additions for May. Read on.